Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46.3Revenue $M2.0Net Margin (%)-2,299.7Altman Z-Score-30.3
Enterprise Value $M41.7EPS $-0.5Operating Margin %-2,183.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.4Pre-tax Margin (%)-2,299.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-32.0Quick Ratio2.7Cash flow > EarningsY
Price/Sales18.45-y EBITDA Growth Rate %-29.4Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-94.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-246.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M111ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with DSCO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DSCOGeorge Soros 2014-06-30 Sold Out $1.53 - $2.32
($1.83)
$ 0.42-77%Sold Out0
DSCOGeorge Soros 2014-03-31 Buy $2.14 - $2.73
($2.4)
$ 0.42-83%New holding166,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DSCO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DSCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Simonson StevenSVP, Chief Development Officer 2014-10-28Sell0$0 view
Leone John RDirector 2013-02-19Buy3,000$2.88-85.42 view
Magee Michael LVP, Quality Operations 2012-05-04Sell0$0-85.42 view
Clayton RussellSenior VP, R&D 2011-09-13Sell0$0-85.42 view
Templeton Mary B EsqSenior VP, General Counsel 2011-09-13Sell0$0-85.42 view
LOPEZ DAVID LExecutive VP & Legal Counsel 2010-12-17Sell1,134$3.15-86.67 view
Hoy ThomasVP, Manufacturing 2010-09-30Sell0$0-86.67 view
Tattory John AndrewVP, Principal Acct Officer 2010-08-24Sell0$0-86.67 view
ROSENTHALE MARVIN EDirector 2008-11-20Buy5,003$14.24-97.05 view
CAPETOLA ROBERT JPresident/CEO, Director 2008-11-17Buy667$15.74-97.33 view

Quarterly/Annual Reports about DSCO:

    News about DSCO:

    Articles On GuruFocus.com
    Discovery Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Discovery Laboratories Inc. Reports Operating Results (10-Q/A) Nov 15 2010 
    Discovery Laboratories Inc. Reports Operating Results (10-Q) May 10 2010 
    Discovery Laboratories Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Discovery Laboratories Inc. Reports Operating Results (10-Q) Aug 10 2009 
    Discovery Laboratories Inc. Reports Operating Results (10-Q) May 12 2009 

    More From Other Websites
    DISCOVERY LABORATORIES INC /DE/ Financials Aug 21 2015
    10-Q for Discovery Laboratories, Inc. Aug 12 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 10 2015
    Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial Results Aug 10 2015
    Q2 2015 Discovery Laboratories Inc Earnings Release - After Market Close Aug 10 2015
    Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015... Aug 03 2015
    Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of... Jul 30 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 24 2015
    Discovery Labs Announces Completion of $40.25 Million Public Offering Jul 22 2015
    Bucks biopharmaceutical firm wants to raise $35 million Jul 20 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 17 2015
    Discovery Labs Announces Pricing of $35 Million Public Offering of Common Stock, Warrants and... Jul 17 2015
    Discovery Labs Announces Proposed Public Offering of Common Stock, Warrants and Pre-funded Warrants Jul 16 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 09 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 01 2015
    Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price Jul 01 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 09 2015
    Discovery Labs Announces Enrollment of First Patient in AEROSURF® Phase 2a Dose Expansion Trial May 20 2015
    DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 15 2015
    Discovery Labs Announces Results of Phase 2a Clinical Trial of AEROSURF® May 14 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK